{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:27:40Z","timestamp":1790224060049,"version":"4.1.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T00:00:00Z","timestamp":1553385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"PHRC programme","award":["AOR17082"],"award-info":[{"award-number":["AOR17082"]}]},{"name":"AFPCA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,24]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>CD4+ regulatory T cells (Treg) expressing the forkhead box protein 3 (FOXP3) transcription factor (Tregs) are instrumental for the prevention of autoimmune diseases. There is increasing evidence that the human T regulatory population is highly heterogeneous in phenotype and function. Numerous studies conducted in human autoimmune diseases have shown that Treg cells are impaired either in their suppressive function, in number, or both. However, the contribution of the FOXP3+ Treg subpopulations to the development of autoimmunity has not been delineated in detail. Rare genetic disorders that involve deficits in Treg function can be studied to develop a global idea of the impact of partial or complete deficiency in a specific molecular mechanism involved in Treg function. In patients with reduced Treg numbers (but no functional deficiency), the expansion of autologous Treg cells could be a suitable therapeutic approach: either infusion of in-vitro autologous expanded cells, infusion of interleukin (IL)-2\/anti-IL-2 complex, or both. Treg biology-based therapies may not be suitable in patients with deficits of Treg function, unless their deficit can be corrected in vivo\/in vitro. Finally, it is critical to consider the appropriate stage of autoimmune diseases at which administration of Treg cellular therapy can be most effective. We discuss conflicting data regarding whether Treg cells are more effectual at preventing the initiation of autoimmunity, ameliorating disease progression or curing autoimmunity itself.<\/jats:p>","DOI":"10.1111\/cei.13288","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:38:53Z","timestamp":1551721133000},"page":"24-35","source":"Crossref","is-referenced-by-count":79,"title":["The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases"],"prefix":"10.1093","volume":"197","author":[{"given":"A","family":"Mohr","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Centre d\u2019immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Atif","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Centre d\u2019immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Balderas","sequence":"additional","affiliation":[{"name":"BD Biosciences, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gorochov","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Centre d\u2019immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France"},{"name":"Sorbonne Universit\u00e9, Inserm, Centre d\u2019immunologie et des maladies infectieuses, Paris, France (Cimi-Paris), AP-HP H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Miyara","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Centre d\u2019immunologie et des maladies infectieuses, Paris (Cimi-Paris), Paris, France"},{"name":"Sorbonne Universit\u00e9, Inserm, Centre d\u2019immunologie et des maladies infectieuses, Paris, France (Cimi-Paris), AP-HP H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,24]]},"reference":[{"key":"2021121023174519500_cei13288-bib-0001","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"2021121023174519500_cei13288-bib-0002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0003","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"2021121023174519500_cei13288-bib-0004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"2021121023174519500_cei13288-bib-0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2021121023174519500_cei13288-bib-0006","doi-asserted-by":"crossref","first-page":"e104698","DOI":"10.1371\/journal.pone.0104698","article-title":"In vitro induced regulatory T cells are unique from endogenous regulatory T cells and effective at suppressing late stages of ongoing autoimmunity","volume":"9","author":"Nguyen","year":"2014","journal-title":"PLOS ONE"},{"key":"2021121023174519500_cei13288-bib-0007","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.4049\/jimmunol.171.10.5012","article-title":"CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4","volume":"171","author":"Liu","year":"2003","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0008","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/eji.200940045","article-title":"Role of Treg in immune regulation of allergic diseases","volume":"40","author":"Palomares","year":"2010","journal-title":"Eur J Immunol"},{"key":"2021121023174519500_cei13288-bib-0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2014.06.013","article-title":"The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus","volume":"162","author":"La Rocca","year":"2014","journal-title":"Immunol Lett"},{"key":"2021121023174519500_cei13288-bib-0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2021121023174519500_cei13288-bib-0011","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J Cancer"},{"key":"2021121023174519500_cei13288-bib-0012","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0013","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M","article-title":"Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro","volume":"31","author":"Stephens","year":"2001","journal-title":"Eur J Immunol"},{"key":"2021121023174519500_cei13288-bib-0014","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P","article-title":"Human anergic\/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population","volume":"31","author":"Taams","year":"2001","journal-title":"Eur J Immunol"},{"key":"2021121023174519500_cei13288-bib-0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J Exp Med"},{"key":"2021121023174519500_cei13288-bib-0016","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human CD25(+)CD4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J Exp Med"},{"key":"2021121023174519500_cei13288-bib-0017","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J Exp Med"},{"key":"2021121023174519500_cei13288-bib-0018","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood.V98.9.2736","article-title":"Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells","volume":"98","author":"Ng","year":"2001","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0019","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2021121023174519500_cei13288-bib-0020","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","article-title":"Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25\u2013 T cells","volume":"112","author":"Walker","year":"2003","journal-title":"J Clin Invest"},{"key":"2021121023174519500_cei13288-bib-0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.humimm.2004.05.016","article-title":"Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans","volume":"66","author":"Morgan","year":"2005","journal-title":"Hum Immunol"},{"key":"2021121023174519500_cei13288-bib-0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.12804","article-title":"Phenotypical characterization of regulatory T cells in humans and rodents","volume":"185","author":"Rodr\u00c3\u00adguez-Perea","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2021121023174519500_cei13288-bib-0023","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0024","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.immuni.2018.04.008","article-title":"Proteomic analyses of human regulatory T cells reveal adaptations in signaling pathways that protect cellular identity","volume":"48","author":"Cuadrado","year":"2018","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"2021121023174519500_cei13288-bib-0026","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1002\/jcp.27553","article-title":"Contribution of regulatory T cells to cancer: a review","volume":"234","author":"Najafi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2021121023174519500_cei13288-bib-0027","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1073\/pnas.1508224112","article-title":"Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans","volume":"112","author":"Miyara","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021121023174519500_cei13288-bib-0028","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm.4086","article-title":"Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers","volume":"22","author":"Saito","year":"2016","journal-title":"Nat Med"},{"key":"2021121023174519500_cei13288-bib-0029","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fimmu.2016.00193","article-title":"Breaking free of control: how conventional T cells overcome regulatory T cell suppression","volume":"7","author":"Mercadante","year":"2016","journal-title":"Front Immunol"},{"key":"2021121023174519500_cei13288-bib-0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2021121023174519500_cei13288-bib-0031","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.4049\/jimmunol.1003224","article-title":"CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game","volume":"187","author":"Long","year":"2011","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0032","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"key":"2021121023174519500_cei13288-bib-0033","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/icb.2010.137","article-title":"Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns","volume":"89","author":"Miyara","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"2021121023174519500_cei13288-bib-0034","doi-asserted-by":"crossref","first-page":"e1005","DOI":"10.1002\/cti2.1005","article-title":"Human FOXP3(+) T regulatory cell heterogeneity","volume":"7","author":"Mohr","year":"2018","journal-title":"Clin Transl Immunology"},{"key":"2021121023174519500_cei13288-bib-0035","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2006-02-005660","article-title":"Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death","volume":"108","author":"Fritzsching","year":"2006","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0036","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4049\/jimmunol.1701025","article-title":"Identity and diversity of human peripheral Th and T regulatory cells defined by single-cell mass cytometry","volume":"200","author":"Kunicki","year":"2018","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0037","doi-asserted-by":"crossref","first-page":"104733","DOI":"10.18632\/oncotarget.10914","article-title":"Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells","volume":"8","author":"Miyara","year":"2017","journal-title":"Oncotarget"},{"key":"2021121023174519500_cei13288-bib-0038","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature22360","article-title":"Stability and function of regulatory T cells expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"key":"2021121023174519500_cei13288-bib-0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"2021121023174519500_cei13288-bib-0040","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"key":"2021121023174519500_cei13288-bib-0041","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","article-title":"Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0042","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.12411","article-title":"T follicular regulatory cells","volume":"271","author":"Sage","year":"2016","journal-title":"Immunol Rev"},{"key":"2021121023174519500_cei13288-bib-0043","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue Tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"2021121023174519500_cei13288-bib-0044","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0046","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94075","article-title":"Human lung tumor FOXP3+ Tregs upregulate four \u2018Treg-locking\u2019 transcription factors","volume":"2","author":"Akimova","year":"2017","journal-title":"JCI Insight"},{"key":"2021121023174519500_cei13288-bib-0047","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM199711133372007","article-title":"Pernicious anemia","volume":"337","author":"Toh","year":"1997","journal-title":"N Engl J Med"},{"key":"2021121023174519500_cei13288-bib-0048","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fimmu.2018.01048","article-title":"Foxp3(+) T regulatory cells: still many unanswered questions \u2013 perspective after 20 years of study","volume":"9","author":"Shevach","year":"2018","journal-title":"Front Immunol"},{"key":"2021121023174519500_cei13288-bib-0049","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and-yet-unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2021121023174519500_cei13288-bib-0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"2021121023174519500_cei13288-bib-0051","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"2021121023174519500_cei13288-bib-0052","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"2021121023174519500_cei13288-bib-0053","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.4049\/jimmunol.0804308","article-title":"Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice","volume":"183","author":"Kim","year":"2009","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0054","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"2021121023174519500_cei13288-bib-0055","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1210\/jc.2002-021845","article-title":"Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up","volume":"88","author":"Dittmar","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121023174519500_cei13288-bib-0056","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/iub.1349","article-title":"Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease","volume":"67","author":"Liberal","year":"2015","journal-title":"IUBMB Life"},{"key":"2021121023174519500_cei13288-bib-0057","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0058","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"2021121023174519500_cei13288-bib-0059","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"2021121023174519500_cei13288-bib-0060","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"2021121023174519500_cei13288-bib-0061","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2249.2004.02478.x","article-title":"Differential expression of CTLA-4 among T cell subsets","volume":"136","author":"Jago","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2021121023174519500_cei13288-bib-0062","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12721","article-title":"What did we learn from CTLA-4 insufficiency on the human immune system?","volume":"287","author":"Mitsuiki","year":"2019","journal-title":"Immunol Rev"},{"key":"2021121023174519500_cei13288-bib-0063","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"2021121023174519500_cei13288-bib-0064","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of phenotypes associated with mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J Clin Immunol"},{"key":"2021121023174519500_cei13288-bib-0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0066","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.38715","article-title":"Treg cell function in rheumatoid arthritis is compromised by CTLA-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway","volume":"66","author":"Cribbs","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021121023174519500_cei13288-bib-0067","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2021121023174519500_cei13288-bib-0068","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol Med"},{"key":"2021121023174519500_cei13288-bib-0069","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"2021121023174519500_cei13288-bib-0070","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat Immunol"},{"key":"2021121023174519500_cei13288-bib-0071","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol"},{"key":"2021121023174519500_cei13288-bib-0072","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"Hafler","year":"2007","journal-title":"N Engl J Med"},{"key":"2021121023174519500_cei13288-bib-0073","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"2021121023174519500_cei13288-bib-0074","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2009.03.001","article-title":"Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion","volume":"123","author":"Miyara","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021121023174519500_cei13288-bib-0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","article-title":"TREG-cell therapies for autoimmune rheumatic diseases","volume":"10","author":"Miyara","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2021121023174519500_cei13288-bib-0076","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: biology, design and application","volume":"36","author":"Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol"},{"key":"2021121023174519500_cei13288-bib-0077","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1182\/blood-2014-07-587493","article-title":"Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy","volume":"124","author":"Van Gool","year":"2014","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0078","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"2021121023174519500_cei13288-bib-0079","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody\u2013cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"2021121023174519500_cei13288-bib-0080","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/eji.201040617","article-title":"Revisiting the role of IL-2 in autoimmunity","volume":"40","author":"Dooms","year":"2010","journal-title":"Eur J Immunol"},{"key":"2021121023174519500_cei13288-bib-0081","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.1800907","article-title":"IL-2\/CD25: a long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2 receptor on regulatory T-cells","volume":"201","author":"Ward","year":"2018","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0082","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur J Immunol"},{"key":"2021121023174519500_cei13288-bib-0083","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0084","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur J Immunol"},{"key":"2021121023174519500_cei13288-bib-0085","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fimmu.2017.00748","article-title":"Alloantigen-induced regulatory T cells generated in presence of vitamin C display enhanced stability of Foxp3 expression and promote skin allograft acceptance","volume":"8","author":"Nikolouli","year":"2017","journal-title":"Front Immunol"},{"key":"2021121023174519500_cei13288-bib-0086","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"2021121023174519500_cei13288-bib-0087","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0088","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0089","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"2021121023174519500_cei13288-bib-0090","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0091","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11926-016-0617-5","article-title":"Low-dose IL-2 in the treatment of lupus","volume":"18","author":"Mizui","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"2021121023174519500_cei13288-bib-0092","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"2021121023174519500_cei13288-bib-0093","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"2021121023174519500_cei13288-bib-0094","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127\u2013 T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin Immunol"},{"key":"2021121023174519500_cei13288-bib-0095","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"key":"2021121023174519500_cei13288-bib-0096","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1172\/JCI90598","article-title":"Transplant trials with Tregs: perils and promises","volume":"127","author":"Tang","year":"2017","journal-title":"J Clin Invest"},{"key":"2021121023174519500_cei13288-bib-0097","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.4049\/jimmunol.169.11.6210","article-title":"Inhibition of human CD4(+)CD25(+high) regulatory T cell function","volume":"169","author":"Baecher-Allan","year":"2002","journal-title":"J Immunol"},{"key":"2021121023174519500_cei13288-bib-0098","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs beta-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"2021121023174519500_cei13288-bib-0099","first-page":"286","article-title":"Extra-articular manifestations in rheumatoid arthritis","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica (Buchar)"},{"key":"2021121023174519500_cei13288-bib-0100","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13288","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/197\/1\/24\/41637580\/cei13288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/197\/1\/24\/41637580\/cei13288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T10:39:18Z","timestamp":1721039958000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/197\/1\/24\/6402558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,24]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,24]]},"published-print":{"date-parts":[[2019,6,24]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13288","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,3,24]]}}}